Genvor grants CFO option on 575K shares (split-adjustable)
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Genvor Inc Chief Financial Officer Donald A. Kalkofen received a direct grant of a nonqualified option covering 575,000 common shares on November 19, 2026. Its $0.2664-per-share exercise price and share amount are stated before any reverse stock split and are subject to proportionate adjustment under the 2026 Omnibus Equity Incentive Plan. Of the option, 425,000 shares vest in 12 equal monthly installments on anniversaries of May 18, 2026, with installments dated before the grant vesting on the grant date; the remaining 150,000 shares vest upon an Uplisting Event. Exercise is barred until a Form S-8 covering the shares becomes effective; the option expires November 19, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Nonqualified Stock Option (right to buy) F1, F2, F3 | 575,000 | $0.00 | $0.00 |
Footnotes (3)
- F1. The exercise price equals the fair market value of a share of common stock on the date of grant, determined under the Issuer's 2026 Omnibus Equity Incentive Plan as the average of the closing bid and asked prices on the OTCQB market for the last preceding date on which there was a sale, which was November 18, 2026.
- F2. Share amounts are stated before any reverse stock split. The number of shares subject to the option and the exercise price are subject to proportionate adjustment under the Plan for any reverse stock split or other change in capitalization.
- F3. The option was granted under the Issuer's 2026 Omnibus Equity Incentive Plan pursuant to the Reporting Person's Amended and Restated Acting Chief Financial Officer Services Agreement dated May 21, 2026. As to 425,000 shares, the option vests in twelve equal monthly installments on each monthly anniversary of May 18, 2026, with installments whose vesting dates preceded the grant date vested on the grant date; as to 150,000 shares, the option vests in full upon an Uplisting Event as defined in that agreement. The option may not be exercised until a registration statement on Form S-8 covering the underlying shares has become effective. The grant was approved by the Issuer's Board of Directors and is exempt under Rule 16b-3(d).
Key Figures
Key Terms
Nonqualified Stock Option (right to buy) technical
2026 Omnibus Equity Incentive Plan technical
Uplisting Event technical
Form S-8 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many stock options did Genvor (GNVR) CFO Donald A. Kalkofen receive?
What is the exercise price of Genvor (GNVR)'s option grant?
How does Genvor (GNVR)'s option grant vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.